Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: A Pediatric Brain Tumor Consortium report

Stewart Goldman*, Ian F. Pollack, Regina I. Jakacki, Catherine A. Billups, Tina Y. Poussaint, Adekunle M. Adesina, Ashok Panigrahy, Donald W. Parsons, Alberto Broniscer, Giles W. Robinson, Nathan J. Robison, Sonia Partap, Lindsay B. Kilburn, Arzu Onar-Thomas, Ira J. Dunkel, Maryam Fouladi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: A Pediatric Brain Tumor Consortium report'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science